Federal
Title 42 — Public Health and Welfare
8,465 sections, each with the official text and a plain-English explanation of what it means for you.
- § 283g — Muscular dystrophy; initiative through Director of National Institutes of Health
- § 283h, 283i — Transferred
- § 283j — Repealed. Pub. L. 114–255, div. A, title II, § 2042(f)(1) , Dec. 13, 2016 , 130 Stat. 1073
- § 283k — Biomedical and behavioral research facilities
- § 283l — Construction of regional centers for research on primates
- § 283m — Sanctuary system for surplus chimpanzees
- § 283n — Shared Instrumentation Grant Program
- § 283o — Next generation of researchers
- § 283p — Population focused research
- § 283q — Eureka prize competitions
- § 283r — National Science Advisory Board for Biosecurity
- § 284 — Directors of national research institutes
- § 2841 to 2856 — Repealed. Pub. L. 97–35, title VI, § 683(a) , Aug. 13, 1981 , 95 Stat. 519
- § 284a — Advisory councils
- § 284b — Repealed. Pub. L. 109–482, title I, § 104(b)(1)(C) , Jan. 15, 2007 , 120 Stat. 3693
- § 284c — Certain uses of funds
- § 284d — Definitions
- § 284e — Research on osteoporosis, Paget’s disease, and related bone disorders
- § 284f — Parkinson’s disease
- § 284g — Expansion, intensification, and coordination of activities of National Institutes of Health with respect to research on autism spectrum disorder
- § 284h — Pediatric Research Initiative
- § 284i — Autoimmune diseases
- § 284j — Muscular dystrophy research
- § 284k — Clinical research
- § 284l — Enhancement awards
- § 284m — Program for pediatric studies of drugs
- § 284m–1 — Pediatric Advisory Committee
- § 284n — Certain demonstration projects
- § 284o — Activities of the National Institutes of Health with respect to research on paralysis
- § 284p — Activities of the National Institutes of Health with respect to research with implications for enhancing daily function for persons with paralysis
- § 284q — Pain research
- § 284q–1 — NIH opioid research
- § 284r — Basic research
- § 284s — Tick-borne diseases
- § 285 — Purpose of Institute
- § 285a — National Cancer Program
- § 285a–1 — Cancer control programs
- § 285a–10 — Research, information, and education with respect to blood cancer
- § 285a–11 — Pediatric cancer research, awareness, and survivorship
- § 285a–11a — Cancer survivorship programs
- § 285a–11b — Best practices for long-term follow-up services for pediatric cancer survivors
- § 285a–12 — Interagency Breast Cancer and Environmental Research Coordinating Committee
- § 285a–13 — Scientific framework for recalcitrant cancers
- § 285a–2 — Special authorities of Director
- § 285a–3 — National cancer research and demonstration centers
- § 285a–4 — President’s Cancer Panel; establishment, membership, etc., functions
- § 285a–5 — Associate Director for Prevention; appointment; function
- § 285a–6 — Breast and gynecological cancers
- § 285a–7 — Prostate cancer
- § 285a–8 — Repealed. Pub. L. 109–482, title I, § 103(b)(15) , Jan. 15, 2007 , 120 Stat. 3687
- § 285a–9 — Grants for education, prevention, and early detection of radiogenic cancers and diseases
- § 285b — Purpose of Institute
- § 285b–1 — Heart, blood vessel, lung, and blood disease prevention and control programs
- § 285b–2 — Information and education
- § 285b–3 — National Heart, Blood Vessel, Lung, and Blood Diseases and Blood Resources Program; administrative provisions
- § 285b–4 — National research and demonstration centers
- § 285b–5 — Repealed. Pub. L. 100–607, title I, § 129 , Nov. 4, 1988 , 102 Stat. 3055
- § 285b–6 — Associate Director for Prevention; appointment; function
- § 285b–7 — National Center on Sleep Disorders Research
- § 285b–7a — Heart attack, stroke, and other cardiovascular diseases in women
- § 285b–7b — Coordination of Federal asthma activities
- § 285b–7c — Tuberculosis
- § 285b–8 — Congenital heart disease
- § 285b–9 — HHS valvular heart disease activities
- § 285c — Purpose of Institute
- § 285c–1 — Data systems and information clearinghouses
- § 285c–2 — Division Directors for Diabetes, Endocrinology, and Metabolic Diseases, Digestive Diseases and Nutrition, and Kidney, Urologic, and Hematologic Diseases; functions
- § 285c–3 — Interagency coordinating committees
- § 285c–4 — Advisory boards
- § 285c–5 — Research and training centers; development or expansion
- § 285c–6 — Advisory council subcommittees
- § 285c–7 — Biennial report
- § 285c–8 — Nutritional disorders program
- § 285c–9 — Juvenile diabetes
- § 285d — Purpose of Institute
- § 285d–1 — National arthritis and musculoskeletal and skin diseases program
- § 285d–2 — Research and training
- § 285d–3 — Data system and information clearinghouse
- § 285d–4 — Interagency coordinating committees
- § 285d–5 — Arthritis and musculoskeletal diseases demonstration projects
- § 285d–6 — Multipurpose arthritis and musculoskeletal diseases centers
- § 285d–6a — Lupus
- § 285d–7 — Advisory Board
- § 285d–8 — Juvenile arthritis and related conditions
- § 285e — Purpose of Institute
- § 285e–1 — Special functions
- § 285e–10 — Aging processes regarding women
- § 285e–10a — Alzheimer’s clinical research and training awards
- § 285e–11 — Repealed. Pub. L. 109–482, title I, § 103(b)(26) , Jan. 15, 2007 , 120 Stat. 3688
- § 285e–2 — Alzheimer’s Disease centers
- § 285e–3 — Claude D. Pepper Older Americans Independence Centers
- § 285e–4 — Awards for leadership and excellence in Alzheimer’s disease and related dementias
- § 285e–5 — Research relevant to appropriate services for individuals with Alzheimer’s disease and related dementias and their families
- § 285e–6 — Dissemination of research results
- § 285e–7 — Clearinghouse on Alzheimer’s Disease
- § 285e–8 — Dissemination project
- § 285e–9 — Alzheimer’s disease registry
- § 285f — Purpose of Institute
- § 285f–1 — Research centers regarding chronic fatigue syndrome
- § 285f–2 — Research and research training regarding tuberculosis
- § 285f–3 — Sexually transmitted disease clinical research and training awards
- § 285f–4 — Microbicide research and development
- § 285f–5 — Research centers for pathogens of pandemic concern
- § 285g — Purpose of Institute
- § 285g–1 — Sudden infant death syndrome research
- § 285g–10 — Investment in tomorrow’s pediatric researchers
- § 285g–11 — Research on the health and development effects of media and related technology on infants, children, and adolescents
- § 285g–2 — Research on intellectual disabilities
- § 285g–3 — Associate Director for Prevention; appointment; function
- § 285g–4 — National Center for Medical Rehabilitation Research
- § 285g–5 — Research centers with respect to contraception and infertility
- § 285g–6 — Program regarding obstetrics and gynecology
- § 285g–7 — Child health research centers
- § 285g–8 — Prospective longitudinal study on adolescent health
- § 285g–9 — Fragile X
- § 285h — Purpose of Institute
- § 285i — Purpose of Institute
- § 285i–1 — Clinical research on eye care and diabetes
- § 285j — Purpose of Institute
- § 285j–1 — Spinal cord regeneration research
- § 285j–2 — Bioengineering research
- § 285j–3 — Research on multiple sclerosis
- § 285k — National Institute of General Medical Sciences
- § 285l — Purpose of Institute
- § 285l–1 — Applied Toxicological Research and Testing Program
- § 285l–2 — Definitions
- § 285l–3 — Interagency Coordinating Committee on the Validation of Alternative Methods
- § 285l–4 — Federal agency action
- § 285l–5 — Application
- § 285l–6 — Methods of controlling certain insect and vermin populations
- § 285m — Purpose of Institute
- § 285m–1 — National Deafness and Other Communication Disorders Program
- § 285m–2 — Data System and Information Clearinghouse
- § 285m–3 — Multipurpose deafness and other communication disorders center
- § 285m–4 — National Institute on Deafness and Other Communication Disorders Advisory Board
- § 285m–5 — Interagency Coordinating Committee
- § 285m–6 — Limitation on administrative expenses
- § 285n — Purpose of Institute
- § 285n–1 — Associate Director for Prevention
- § 285n–2 — National Alcohol Research Centers; mandatory grant for research of effects of alcohol on elderly
- § 285o — Purpose of Institute
- § 285o–1 — Associate Director for Prevention
- § 285o–2 — Drug Abuse Research Centers
- § 285o–3 — Office on AIDS
- § 285o–4 — Medication Development Program
- § 285p — Purpose of Institute
- § 285p–1 — Associate Director for Prevention
- § 285p–2 — Office of Rural Mental Health Research
- § 285p–3 — Office on AIDS
- § 285q — Purpose of Institute
- § 285q–1 — Specific authorities
- § 285q–2 — Advisory council
- § 285q–3 — Repealed. Pub. L. 114–255, div. A, title II, § 2042(h)(1) , Dec. 13, 2016 , 130 Stat. 1073
- § 285r — Purpose of the Institute
- § 285s — Purpose of Institute
- § 285t — Purpose of Institute
- § 285t–1 — Centers of excellence for research education and training
- § 285t–2 — Repealed. Pub. L. 114–255, div. A, title II, § 2022(c)(1) , Dec. 13, 2016 , 130 Stat. 1054
- § 285t–3 — General provisions regarding the Institute
- § 286 — National Library of Medicine
- § 2861 to 2865 — Repealed. Pub. L. 95–568, § 8(a)(2) , Nov. 2, 1978 , 92 Stat. 2428
- § 286a — Board of Regents
- § 286a–1 — Library facilities
- § 286a–2 — Repealed. Pub. L. 109–482, title I, § 103(b)(39) , Jan. 15, 2007 , 120 Stat. 3688
- § 286b — Repealed. Pub. L. 103–43, title XIV, § 1402(b) , June 10, 1993 , 107 Stat. 171
- § 286b–1 — Definitions
- § 286b–2 — National Medical Libraries Assistance Advisory Board
- § 286b–3 — Grants for training in medical library sciences
- § 286b–4 — Assistance for projects in sciences related to health, for research and development in medical library science, and for development of education technologies
- § 286b–5 — Grants for establishing, expanding, and improving basic resources of medical libraries and related instrumentalities
- § 286b–6 — Grants and contracts for establishment of regional medical libraries
- § 286b–7 — Financial support of biomedical scientific publications
- § 286b–8 — Grant payments, records, and audit
- § 286c — Purpose, establishment, functions, and funding of National Center for Biotechnology Information
- § 286d — National Information Center
- § 287 — National Center for Advancing Translational Sciences
- § 2871 — Repealed. Pub. L. 95–568, § 8(a)(2) , Nov. 2, 1978 , 92 Stat. 2428
- § 287a — Cures Acceleration Network
- § 287a–1 — Office of Rare Diseases
- § 287a–2 — Rare disease regional centers of excellence
- § 287a–3, 287a–3a — Transferred
- § 287a–4 — General clinical research centers
- § 287b — General purpose
- § 287c — Transferred
- § 287c–11 — Dietary supplements
- § 287c–21 — Purpose of Center
- § 287c–31 to 287c–34 — Transferred
- § 287d — Office of Research on Women’s Health
- § 287d–1 — National data system and clearinghouse on research on women’s health
- § 287d–2 — Biennial report
- § 288 — Ruth L. Kirschstein National Research Service Awards
- § 288–1 — Intramural loan repayment program
- § 288–2 — Extramural loan repayment program
- § 288–3 — Repealed. Pub. L. 114–255, div. A, title II, § 2022(c)(2) , Dec. 13, 2016 , 130 Stat. 1054
- § 288–4 — Undergraduate scholarship program regarding professions needed by National Research Institutes
- § 288–5 to 288–6 — Repealed. Pub. L. 114–255, div. A, title II, § 2022(c)(3) –(5), Dec. 13, 2016 , 130 Stat. 1054
- § 2881 — Repealed. Pub. L. 97–35, title VI, § 683(a) , Aug. 13, 1981 , 95 Stat. 519
- § 288a — Visiting Scientist Awards
- § 288b — Studies respecting biomedical and behavioral research personnel
- § 289 — Institutional review boards; ethics guidance program